Total Payments
$17,137
2024 Payments
$1,734
Companies
11
Transactions
53
Medicare Patients
766
Medicare Billing
$80,710
Payment Breakdown by Category
Consulting$12,410 (72.4%)
Travel$3,060 (17.9%)
Food & Beverage$1,111 (6.5%)
Other$540.00 (3.2%)
Education$16.25 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $12,410 | 5 | 72.4% |
| Travel and Lodging | $3,060 | 7 | 17.9% |
| Food and Beverage | $1,111 | 26 | 6.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $540.00 | 14 | 3.2% |
| Education | $16.25 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $5,747 | 3 | $0 (2019) |
| UCB, Inc. | $4,387 | 12 | $0 (2024) |
| Janssen Research & Development, LLC | $3,176 | 11 | $0 (2019) |
| GlaxoSmithKline, LLC. | $3,048 | 4 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $540.00 | 14 | $0 (2017) |
| Amgen Inc. | $127.93 | 3 | $0 (2024) |
| Regeneron Pharmaceuticals, Inc. | $30.89 | 1 | $0 (2017) |
| Janssen Scientific Affairs, LLC | $28.62 | 2 | $0 (2024) |
| Genentech USA, Inc. | $21.47 | 1 | $0 (2018) |
| Regeneron Healthcare Solutions, Inc. | $16.25 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,734 | 6 | UCB, Inc. ($1,658) |
| 2023 | $185.53 | 5 | UCB, Inc. ($117.79) |
| 2022 | $2,639 | 2 | GlaxoSmithKline, LLC. ($2,600) |
| 2021 | $41.85 | 2 | UCB, Inc. ($27.91) |
| 2019 | $6,359 | 7 | E.R. Squibb & Sons, L.L.C. ($5,747) |
| 2018 | $5,515 | 15 | Janssen Research & Development, LLC ($2,986) |
| 2017 | $663.57 | 16 | SANOFI-AVENTIS U.S. LLC ($540.00) |
All Payment Transactions
53 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/15/2024 | Janssen Scientific Affairs, LLC | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.68 | General |
| Category: Immunology | ||||||
| 04/25/2024 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $46.92 | General |
| Category: Inflammation | ||||||
| 03/26/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Immunology | ||||||
| 01/04/2024 | UCB, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,610.00 | General |
| 01/04/2024 | UCB, Inc. | — | Travel and Lodging | Cash or cash equivalent | $35.00 | General |
| 01/04/2024 | UCB, Inc. | — | Travel and Lodging | Cash or cash equivalent | $13.10 | General |
| 11/12/2023 | Amgen Inc. | TAVNEOS (Drug) | Food and Beverage | In-kind items and services | $41.94 | General |
| Category: Inflammation | ||||||
| 10/14/2023 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $39.97 | General |
| 03/14/2023 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $40.00 | General |
| 03/14/2023 | UCB, Inc. | — | Food and Beverage | In-kind items and services | $37.82 | General |
| 01/20/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $25.80 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2022 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Consulting Fee | Cash or cash equivalent | $2,600.00 | General |
| Category: IMMUNOLOGY | ||||||
| 06/10/2022 | Amgen Inc. | Tavneos (Drug) | Food and Beverage | In-kind items and services | $39.07 | General |
| Category: Not Applicable | ||||||
| 07/26/2021 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $27.91 | General |
| Category: Immunology | ||||||
| 07/16/2021 | Janssen Scientific Affairs, LLC | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: Immunology | ||||||
| 11/14/2019 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2019 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $122.18 | General |
| 04/22/2019 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Consulting Fee | Cash or cash equivalent | $5,500.00 | General |
| Category: Immunology | ||||||
| 04/22/2019 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Travel and Lodging | Cash or cash equivalent | $226.80 | General |
| Category: Immunology | ||||||
| 04/22/2019 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $19.81 | General |
| Category: Immunology | ||||||
| 01/03/2019 | Janssen Research & Development, LLC | — | Travel and Lodging | Cash or cash equivalent | $164.00 | General |
| 01/03/2019 | Janssen Research & Development, LLC | — | Food and Beverage | Cash or cash equivalent | $25.81 | General |
| 11/10/2018 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $28.49 | General |
| 11/10/2018 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $24.99 | General |
| 11/09/2018 | Janssen Research & Development, LLC | — | Travel and Lodging | In-kind items and services | $1,600.17 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 215 | 319 | $89,833 | $25,912 |
| 2022 | 5 | 200 | 263 | $66,768 | $20,908 |
| 2021 | 5 | 170 | 230 | $57,845 | $19,273 |
| 2020 | 6 | 181 | 216 | $48,046 | $14,618 |
Total Patients
766
Total Services
1,028
Medicare Billing
$80,710
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 131 | 231 | $59,443 | $16,907 | 28.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 37 | 37 | $13,901 | $4,131 | 29.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 14 | 14 | $7,166 | $2,072 | 28.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 14 | $5,342 | $1,603 | 30.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 23 | $3,982 | $1,199 | 30.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 107 | 164 | $35,869 | $11,200 | 31.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 36 | 36 | $12,913 | $3,832 | 29.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 19 | 19 | $8,910 | $2,809 | 31.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 16 | 17 | $5,242 | $1,802 | 34.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 22 | 27 | $3,834 | $1,264 | 33.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 87 | 142 | $30,482 | $10,344 | 33.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 31 | 31 | $10,893 | $3,011 | 27.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 17 | 17 | $7,801 | $2,652 | 34.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 15 | 19 | $5,746 | $2,214 | 38.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 20 | 21 | $2,923 | $1,052 | 36.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 77 | 111 | $22,167 | $6,400 | 28.9% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 27 | 27 | $11,180 | $3,700 | 33.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 17 | 17 | $5,547 | $1,552 | 28.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 16 | 16 | $4,409 | $1,212 | 27.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 26 | 27 | $2,464 | $1,034 | 42.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 18 | 18 | $2,279 | $719.64 | 31.6% |
About Dr. Kwanghoon Han, MD
Dr. Kwanghoon Han, MD is a Rheumatology healthcare provider based in Seattle, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1740201615.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kwanghoon Han, MD has received a total of $17,137 in payments from pharmaceutical and medical device companies, with $1,734 received in 2024. These payments were reported across 53 transactions from 11 companies. The most common payment nature is "Consulting Fee" ($12,410).
As a Medicare-enrolled provider, Han has provided services to 766 Medicare beneficiaries, totaling 1,028 services with total Medicare billing of $80,710. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Seattle, WA
- Active Since 07/23/2006
- Last Updated 09/14/2016
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1740201615
Products in Payments
- ORENCIA (Biological) $5,747
- BENLYSTA (Biological) $2,926
- SYNVISC-ONE (Device) $540.00
- STELARA (Biological) $112.72
- TAVNEOS (Drug) $88.86
- KEVZARA SARILUMAB INJECTION (Biological) $47.14
- Tavneos (Drug) $39.07
- TREMFYA (Drug) $28.62
- Cimzia (Drug) $27.91
- Actemra (Biological) $21.47
- TALTZ (Drug) $14.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Seattle
Philip Mease, Md, MD
Rheumatology — Payments: $2.9M
Rheumatology $2.9M
Jane Buckner, Md, MD
Rheumatology — Payments: $71,520
Rheumatology $71,520
Dr. Namrata Singh, M.d, M.D
Rheumatology — Payments: $15,855
Rheumatology $15,855
Myriam Guevara, Md, MD
Rheumatology — Payments: $14,597
Rheumatology $14,597
Steven Overman, Md, MD
Rheumatology — Payments: $13,800
Rheumatology $13,800
Dr. Anthony Krajcer, M.d, M.D
Rheumatology — Payments: $12,524
Rheumatology $12,524